Amdocs Limited (NASDAQ:DOX – Get Free Report) Director John Anthony Macdonald acquired 1,000 shares of Amdocs stock in a transaction that occurred on Tuesday, November 10th. The shares were bought at an average cost of $41.63 per share, with a total value of $41,630.00. Following the transaction, the director owned 25,189 shares in the company, valued at $1,048,618.07. This represents a 4.13% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.
Amdocs Stock Up 2.4%
NASDAQ:DOX traded up $1.05 during trading hours on Thursday, reaching $44.17. 327,803 shares of the company traded hands, compared to its average volume of 1,311,953. The business’s 50-day moving average price is $58.25 and its two-hundred day moving average price is $61.37. The stock has a market capitalization of $4.77 billion, a P/E ratio of 9.44, a P/E/G ratio of 1.35 and a beta of 0.42. Amdocs Limited has a 1 year low of $39.96 and a 1 year high of $84.95. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.
Amdocs (NASDAQ:DOX – Get Free Report) last released its earnings results on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, hitting the consensus estimate of $1.98. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The business had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.19 billion. During the same period in the previous year, the company posted $1.83 earnings per share. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year. Analysts predict that Amdocs Limited will post 5.82 earnings per share for the current year.
Amdocs Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a $0.5690 dividend. This represents a $2.28 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend is Thursday, December 31st. Amdocs’s payout ratio is currently 48.61%.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Pzena Investment Management LLC lifted its holdings in shares of Amdocs by 3.4% during the third quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company’s stock valued at $826,532,000 after purchasing an additional 469,581 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Amdocs by 19.7% during the first quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company’s stock valued at $226,045,000 after buying an additional 571,036 shares during the last quarter. Bank of America Corp DE increased its holdings in Amdocs by 29.1% in the 1st quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company’s stock worth $82,375,000 after buying an additional 284,435 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Amdocs by 11.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,112,976 shares of the technology company’s stock worth $63,703,000 after buying an additional 111,800 shares in the last quarter. Finally, First Trust Advisors LP raised its position in Amdocs by 13.9% in the 1st quarter. First Trust Advisors LP now owns 1,077,258 shares of the technology company’s stock worth $70,302,000 after buying an additional 131,197 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Amdocs News Summary
Here’s some of the latest news about DOX:
- Positive Sentiment: Two directors disclosed purchases on November 10: Veronique Morali bought 134 shares and John Anthony Macdonald bought 1,000 shares, at average prices of $41.31 and $41.63. The buying may signal confidence, though the transactions were relatively small. Morali SEC filing Macdonald SEC filing
- Negative Sentiment: The central concern remains Amdocs’ fiscal 2027 outlook, reportedly weakened by an escalating T-Mobile dispute. The resulting disappointment was associated with a roughly 30% one-session share decline on November 4, despite quarterly results being in line with expectations. Levi & Korsinsky notice
- Negative Sentiment: Zacks Research downgraded Amdocs from “hold” to “strong sell,” adding to the cautious analyst sentiment. Zacks Research ratings
Analyst Upgrades and Downgrades
Several brokerages recently commented on DOX. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 23rd. Oppenheimer lowered shares of Amdocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Zacks Research cut shares of Amdocs from a “hold” rating to a “strong sell” rating in a report on Monday. Stifel Nicolaus dropped their target price on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. Finally, Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $69.00.
Get Our Latest Stock Analysis on DOX
About Amdocs
Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.
Read More
- Five stocks we like better than Amdocs
- CoreWeave’s Backlog Is Surging—Can the Stock Follow?
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
